glp 1 receptor antagonists 𝗧𝗵𝗲 𝗘𝗳𝗳𝗲𝗰𝘁 𝗼𝗳 𝗚𝗟𝗣-𝟭 𝗥𝗲𝗰𝗲𝗽𝘁𝗼𝗿 𝗔𝗴𝗼𝗻𝗶𝘀𝘁𝘀 𝗼𝗻 𝗚𝗹𝘆𝗰𝗮𝘁𝗲𝗱 𝗛𝗲𝗺𝗼𝗴𝗹𝗼𝗯𝗶𝗻 𝗟𝗲𝘃𝗲𝗹𝘀 ⁣ ⁣ Randomized, placebo-controlled trials of the glucagon-like peptide-1 (GLP-1) agonists have provided strong GLP-1 actions and target organs.

From a scientific perspective, the next critical step would be rigorous, independent, international clinical trials with proper controls, blinding, and standardized outcome measures

Rogers MB, Simon D, Firek B, Silfies L, Fabio A, Bell MJ, et al

Moses AC, Young SC, Morrow LA, OBrien M, Clemmons DR

Hydration and Electrolytes Conscious hydration is non-negotiable for fighting GLP-1 fatigue

This peptide doesnt contain cortisol, acetylcholine, prolactin, or aldosterone levels, which are hormones associated with adverse side effects

Below is a list of some of the diseases and issues associated with glutathione deregulation or deficiency: Aging and related disorders Alzheimers disease Cancer (ovarian, bladder, etc.) Chronic liver disease Cognitive impairment Cystic fibrosis Diabetes, especially uncontrolled diabetes HIV/AIDS Hypertension Infertility in both men and women Lupus Mental health disorders Multiple sclerosis Neurodegenerative disorders Parkinsons disease Preeclampsia Ulcerative colitis There are some common polymorphisms or SNPs that impact glutathione and associated processes